These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36041497)

  • 1. Neuropeptide apelin presented in the dopaminergic neurons modulates the neuronal excitability in the substantia nigra pars compacta.
    Liu C; Kang NW; Wang Y; Xue Y; Chen XY; Chen L
    Neuropharmacology; 2022 Nov; 219():109235. PubMed ID: 36041497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons.
    Chen L; Liu C; Xue Y; Chen XY
    Neuropeptides; 2023 Jun; 99():102337. PubMed ID: 37087783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice.
    Liu C; Liu WH; Yang W; Chen L; Xue Y; Chen XY
    Neuropharmacology; 2024 Jul; 252():109946. PubMed ID: 38599494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats.
    Liu C; Xue Y; Liu MF; Wang Y; Liu ZR; Diao HL; Chen L
    J Neurochem; 2018 Nov; 147(3):380-394. PubMed ID: 30102759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changed firing activity of nigra dopaminergic neurons in Parkinson's disease.
    Chen XY; Liu C; Xue Y; Chen L
    Neurochem Int; 2023 Jan; 162():105465. PubMed ID: 36563966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effects of L-DOPA on nigral dopaminergic neurons.
    Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
    Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin-13 Protects Dopaminergic Neurons against Rotenone-Induced Neurotoxicity through the AMPK/mTOR/ULK-1 Mediated Autophagy Activation.
    Chen P; Wang Y; Chen L; Song N; Xie J
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy.
    Zhu J; Dou S; Jiang Y; Chen J; Wang C; Cheng B
    Brain Res; 2019 Jul; 1715():203-212. PubMed ID: 30914252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons.
    Tepper JM; Martin LP; Anderson DR
    J Neurosci; 1995 Apr; 15(4):3092-103. PubMed ID: 7722648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
    J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic stimulation-induced synaptic responses in substantia nigra pars compacta dopaminergic neurons in vitro.
    Iribe Y; Moore K; Pang KC; Tepper JM
    J Neurophysiol; 1999 Aug; 82(2):925-33. PubMed ID: 10444687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent changes in dopaminergic neuron firing patterns in substantia nigra pars compacta.
    Ishida Y; Kozaki T; Isomura Y; Ito S; Isobe K
    J Neural Transm Suppl; 2009; (73):129-33. PubMed ID: 20411773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease.
    Yu H; Liu X; Chen B; Vickstrom CR; Friedman V; Kelly TJ; Bai X; Zhao L; Hillard CJ; Liu QS
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographic heterogeneity of substantia nigra neurons: diversity in intrinsic membrane properties and synaptic inputs.
    Hajós M; Greenfield SA
    Neuroscience; 1993 Aug; 55(4):919-34. PubMed ID: 7901802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.